Reiher L, Vosberg H, Sandmann W
Klinik für Gefässchirurgie und Nierentransplantation, Heinrich Heine Universität Düsseldorf, Germany.
Vasa. 2001 Feb;30(1):21-3. doi: 10.1024/0301-1526.30.1.21.
Prostaglandin E1 (PGE1) is known to have a positive effect on kidney function after kidney ischaemia due to aortic clamping. Side effects of PGE1 are a decrease of systemic blood pressure and prevention of thrombocyte clotting, both being undesired during repair of thoracoabdominal aortic aneurysms (TAA). The aim of this study was to evaluate, whether intraoperative and intraarterial kidney perfusion with 4 degrees Ringer's lactate plus 1000 IU of heparin/l plus 20 micrograms PGE1/l is more effective in preventing postischaemic kidney dysfunction than cold perfusion without PGE1.
In the time period from I/1996 until X/1998 58 patients underwent aortic repair for TAA type II, III, or IV (Crawford's classification). Ten patients fulfilled the criteria for this study: renal artery stenosis or occlusion was excluded by angiography pre- and postoperatively. By means of szintigraphy an at least 30% participation in renal function had to be proven for every kidney. Intraoperatively both kidneys had to be excluded from circulation simultaneously. The left kidney in each patient was perfused with 4 degrees Ringer's lactate plus 1000 IU of heparin/l plus 20 micrograms PGE1/l. The right kidney was perfused with a solution of the same temperature plus heparin but without PGE1.
There was an intermittent increase of creatinin and/or urea in each patient postoperatively. By renal szintigraphy, which was performed after a mean time of 9 (5-13) days postoperatively, a shift of renal function from one kidney to the other could be excluded.
In this experimental setting no additional benefit for kidney function could be detected, when under conditions of ischaemia kidneys were perfused with 4 degrees Ringer's lactate plus 1000 IU of heparin/l plus 20 micrograms PGE1/l compared to kidneys perfused with the same solution without PGE1.
已知前列腺素E1(PGE1)对因主动脉夹闭导致的肾脏缺血后的肾功能有积极作用。PGE1的副作用是系统性血压降低和抑制血小板凝血,这在胸腹主动脉瘤(TAA)修复过程中都是不理想的。本研究的目的是评估术中经动脉用4℃乳酸林格氏液加1000IU肝素/升加20微克PGE1/升进行肾脏灌注,在预防缺血后肾功能障碍方面是否比不用PGE1的冷灌注更有效。
在1996年1月至1998年10月期间,58例患者接受了II、III或IV型(克劳福德分类法)TAA的主动脉修复手术。10例患者符合本研究标准:术前和术后血管造影排除肾动脉狭窄或闭塞。通过闪烁扫描术必须证明每个肾脏至少有30%的肾功能参与。术中两个肾脏必须同时排除在循环之外。每位患者的左肾用4℃乳酸林格氏液加1000IU肝素/升加20微克PGE1/升灌注。右肾用相同温度加肝素的溶液灌注,但不含PGE1。
术后每位患者的肌酐和/或尿素均有间歇性升高。术后平均9(5 - 13)天进行的肾脏闪烁扫描术排除了肾功能从一个肾脏转移到另一个肾脏的可能性。
在本实验环境中,与用不含PGE1的相同溶液灌注肾脏相比,在缺血条件下用4℃乳酸林格氏液加1000IU肝素/升加20微克PGE1/升灌注肾脏,未发现对肾功能有额外益处。